The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Open accessAbstract
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alphabeta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alphabeta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, it is no surprise that IFN-β transcriptome signatures were found to be associated with active but not latent TB (101).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L. B., Palucka, K., Arce, E., Cantrell, V., Borvák, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,990
Self-citationBlood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,744
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,441
Self-citationCell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D., Blankenship, D., Li, L., Munagala, I., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.012 · Cited by 649
Self-citationImmunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636
Flagged first, then by citations
Research works printed but not linked: 2
- Dye, C., Floyd, K. & Uplekar, M. in Global Tuberculosis Control: Surveillance, Planning, Financing Ch. 1, 17–37 (World Health Organization, 2008)
- Falk, A. & O’Connor, J. B. in Diagnosis Standards and Classification of Tuberculosis, vol. 12 (eds Falk, A. et al.), 68–76 (National Tuberculosis and Respiratory Disease Association, 1969)
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Shojaan, H., Kalami, N., Alamdari, M. G., Alorizy, S. M. E., Ghaedi, A., Bazrgar, A., Khanzadeh, M., Lucke-Wold, B. P., & Khanzadeh, S. (2023) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2023.100395 · Cited by 28
Type I interferons in regulation of mucosal immunity
Mangan, N. E., & Fung, K. Y. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.13 · Cited by 25
Subramaniam, K. S., Spaulding, E., Ivan, E., Mutimura, E., Kim, R. S., Liu, X., Dong, C., Feintuch, C. M., Zhang, X., Anastos, K., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv217 · Cited by 25
Type I Interferons Promote Severe Disease in a Mouse Model of Lethal Ehrlichiosis
Zhang, Y., Thai, V., McCabe, A. F., Jones, M., & MacNamara, K. C. (2014) · Infection and Immunity · doi:10.1128/iai.01564-13 · Cited by 25
Weiner, J. M., & Kaufmann, S. H. E. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.017 · Cited by 25
Validation of Immune Cell Modules in Multicellular Transcriptomic Data
Pollara, G., Murray, M. J., Heather, J., Byng-Maddick, R., Guppy, N., Ellis, M. J., Turner, C. T., Chain, B., & Noursadeghi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169271 · Cited by 25
Rivas-Santiago, C., & Guerrero, G. G. (2017) · BioMed Research International · doi:10.1155/2017/8796760 · Cited by 25
Zheng, X., O’Connell, C. M., Zhong, W., Poston, T. B., Wiesenfeld, H. C., Hillier, S. L., Trent, M., Gaydos, C. A., Tseng, G. C., Taylor, B. D., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00307 · Cited by 25
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
Smith, M. A., Chiang, C.-C., Zerrouki, K., Rahman, S., White, W. I., Streicher, K. L., Rees, W. A., Schiffenbauer, A. I., Rider, L. G., Miller, F. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60563-9 · Cited by 25
Tuberculosis as an unconventional interferonopathy
Vance, R. E. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102508 · Cited by 24
Edwards, C. L., Best, S. E., Gun, S. Y., Claser, C., James, K. R., de, M. M., Sebina, I., Rivera, F. D. L., Amante, F. H., Hertzog, P. J., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444824 · Cited by 24
Zhang, X., Zhu, M., & Hu, X. (2018) · Epigenomics · doi:10.2217/epi-2018-0028 · Cited by 24
Duffy, F. J., Thompson, E. G., Scriba, T. J., & Zak, D. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219322 · Cited by 24
The immunopathogenesis of tuberculous pericarditis
Howlett, P. J., Bruyn, E. D., Morrison, H., Godsent, I. C., Wilkinson, K. A., Ntsekhe, M., & Wilkinson, R. J. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.001 · Cited by 24
Self-citationBurel, J. G., Singhania, A., Dubelko, P., Müller, J., Tanner, R., Parizotto, E. A., Dedicoat, M. J., Fletcher, T. E., Dunbar, J., Cunningham, A. F., et al. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102127 · Cited by 24
Muefong, C. N., Owolabi, O., Donkor, S. A., Charalambous, S., Mendy, J., Sey, I. C. M., Bakuli, A., Rachow, A., Geldmacher, C., & Sutherland, J. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740933 · Cited by 27
Geng, X., Wu, X., Yang, Q., Xin, H., Zhang, B., Wang, D., Liu, L., Liu, S., Chen, Q., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954221 · Cited by 28
SOCS1 Gene Expression is Increased in Severe Pulmonary Tuberculosis
Masood, K. I., Rottenberg, M. E., Carow, B., Rao, N., Ashraf, M., Hussain, R., & Hasan, Z. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02731.x · Cited by 25
IL-27 Suppresses Antimicrobial Activity in Human Leprosy
Teles, R. M. B., Kelly‐Scumpia, K. M., Sarno, E. N., Rea, T. H., Ochoa, M. T., Cheng, G., & Modlin, R. L. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.195 · Cited by 24
Circulating B-Lymphocytes as Potential Biomarkers of Tuberculosis Infection Activity
Sebina, I., Biraro, I. A., Dockrell, H. M., Elliott, A. M., & Cose, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106796 · Cited by 24
Finger stick blood collection for gene expression profiling and storage of tempus blood RNA tubes
Rinchai, D., Anguiano, E., Nguyen, P., & Chaussabel, D. (2016) · F1000Research · doi:10.12688/f1000research.8841.1 · Cited by 25
Self-citationSuccessful TB treatment induces B-cells expressing FASL and IL5RA mRNA
van Rensburg, I. C., Wagman, C., Stanley, K., Beltran, C. G. G., Ronacher, K., Walzl, G., & Loxton, A. G. (2016) · Oncotarget · doi:10.18632/oncotarget.12184 · Cited by 25
The frontline of immune response in peripheral blood
Song, F., Qian, Y., Peng, X., Li, X., Xing, P., Ye, D., & Lei, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182294 · Cited by 26
The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis
Maio, F. D., Squeglia, F., Goletti, D., & Delogu, G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181029165805 · Cited by 27
Mycobacterial virulence: impact on immunogenicity and vaccine research
Kroesen, V. M., Madacki, J., Frigui, W., Sayes, F., & Brosch, R. (2019) · F1000Research · doi:10.12688/f1000research.20572.1 · Cited by 24
Liang, S., Xie, M., Tang, J., Wang, M., Zhang, D., & Hou, S. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108813 · Cited by 24
The human condition: an immunological perspective
Germain, R. N., & Schwartzberg, P. L. (2011) · Nature Immunology · doi:10.1038/ni0511-369 · Cited by 24
Hosseini, R., Lamers, G. E. M., Soltani, H. M., Meijer, A. H., Spaink, H. P., & Schaaf, M. J. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.135194 · Cited by 27
Lavalett, L., Ortega, H., & Barrera, L. F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00163 · Cited by 25
Zhou, X., Zhang, L., Lie, L., Zhang, Z., Zhu, B., Yang, J., Gao, Y., Li, P., Huang, Y., Xu, H., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.030 · Cited by 23
Comparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler
Johnson, W. E., Odom-Mabey, A. R., Cintron, C., Muthaiah, M., Knudsen, S., Joseph, N. M., Babu, S. P., Lakshminarayanan, S., Jenkins, D. F., Zhao, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05598-z · Cited by 23
Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females
Nieuwenhuizen, N. E., Żyła, J., Zedler, U., Bandermann, S., Abed, U. A., Brinkmann, V., & Kaufmann, S. H. E. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.09.039 · Cited by 23
van Doorn, C. L. R., Eckold, C., Ronacher, K., Ruslami, R., van Veen, S., Lee, J., Kumar, V., Kerry-Barnard, S. R., Malherbe, S. T., Kleynhans, L., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104173 · Cited by 23
Madden, K., Hamra, R. E., Berton, S., Felker, J., Alvarez, G. G., Blais, A., & Sun, J. (2023) · microLife · doi:10.1093/femsml/uqad006 · Cited by 26
Singh, A. K., Wang, R., Lombardo, K. A., Praharaj, M., Bullen, C. K., Um, P. K., Gupta, M., Srikrishna, G., Davis, S. L., Komm, O. D., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107733 · Cited by 24
Age and sex influence antibody profiles associated with tuberculosis progression
Davies, L. R. L., Wang, C., Steigler, P., Bowman, K. A., Fischinger, S., Hatherill, M., Fisher, M., Mbandi, S. K., Rodo, M., Ottenhoff, T. H. M., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01678-x · Cited by 23
Mwaba, P., McNerney, R., Grobusch, M. P., O’Grady, J., Bates, M., Kapata, N., Maeurer, M. J., & Zumla, A. I. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02777.x · Cited by 23
Talwar, H. S., Rosati, R., Li, J., Kissner, D. G., Ghosh, S., Fernández-Madrid, F., & Samavati, L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.007 · Cited by 23
Investigation of the effect of Mycobacterium bovis infection on bovine neutrophils functions
Wang, J., Zhou, X., Pan, B., Yang, L., Yin, X., Xu, B., & Zhao, D. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.07.002 · Cited by 23
Patrick, K. L., Bell, S. L., & Watson, R. O. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.030 · Cited by 24
Unravelling the networks dictating host resistance versus tolerance during pulmonary infections
Meunier, I., Kaufmann, E., Downey, J., & Divangahi, M. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2572-5 · Cited by 23
Clayton, K., Polak, M. E., Woelk, C. H., & Elkington, P. T. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1248le · Cited by 23
Li, H., Wei, S., Yuan, F., Li, M., Li, X., Li, Z., Zhang, J., Zhu, G., Li, C., Bi, L., et al. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx080 · Cited by 23
Keegan, C., Krutzik, S. R., Schenk, M., Scumpia, P. O., Lu, J. N., Pang, Y. L. J., Russell, B. S., Lim, K. S., Shell, S. S., Prestwich, E. G., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701733 · Cited by 24
Balcells, M. E., Ruiz-Tagle, C., Tiznado, C., García, P., & Naves, R. F. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.006 · Cited by 23
Spolski, R. J., West, E. E., Li, P., Veenbergen, S., Yung, S. C., Kazemian, M., Oh, J., Yu, Z., Freeman, A. F., Holland, S. M., et al. (2019) · eLife · doi:10.7554/elife.45501 · Cited by 23
Leisching, G. R., Ali, A. T., Cole, V., & Baker, B. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.12.004 · Cited by 23
Impact and prognosis of the expression of IFN-α among tuberculosis patients
Taneja, V., Kalra, P., Goel, M., Khilnani, G. C., Saini, V., Prasad, G. B. K. S., Gupta, U. D., & Prasad, H. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235488 · Cited by 23
Salzer, H. J. F., Wassilew, N., Köhler, N., Olaru, I. D., Günther, G., Herzmann, C., Kalsdorf, B., Carballo, P. M. S., Terhalle, E., Rolling, T., et al. (2016) · Respiration · doi:10.1159/000449037 · Cited by 22
Bah, S. Y., Forster, T., Dickinson, P., Kampmann, B., & Ghazal, P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00457 · Cited by 22
Gong, Z. H., Gu, Y., Xiong, K., Niu, J., Zheng, R., Su, B., Fan, L., & Xie, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.650567 · Cited by 22
Vargas, R., Abbott, L. E., Bower, D., Frahm, N., Shaffer, M., & Yu, W. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010770 · Cited by 22
Vaccine development against tuberculosis before and after Covid-19
Kaufmann, S. H. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1273938 · Cited by 22
A review of clinical models for the evaluation of human TB vaccines
O’Shea, M. K., & McShane, H. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1134407 · Cited by 22
Lienard, J., Movert, E., Valfridsson, C., Sturegård, E., & Carlsson, F. (2016) · Cellular Microbiology · doi:10.1111/cmi.12594 · Cited by 23
Disease-specific classification using deconvoluted whole blood gene expression
Wang, L., Oh, W. K., & Zhu, J. (2016) · Scientific Reports · doi:10.1038/srep32976 · Cited by 22
Verma, S., Du, P., Nakanjako, D., Hermans, S., Briggs, J. J., Nakiyingi, L., Ellner, J. J., Manabe, Y. C., & Salgame, P. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3127-4 · Cited by 22
Gopalakrishnan, A., Dietzold, J., Verma, S., Bhagavathula, M., & Salgame, P. (2018) · Infection and Immunity · doi:10.1128/iai.00760-18 · Cited by 22
Ancestry patterns inferred from massive RNA-seq data
Barral‐Arca, R., Pardo‐Seco, J., Bello, X., Martinón‐Torres, F., & Salas, A. (2019) · RNA · doi:10.1261/rna.070052.118 · Cited by 23
Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNA
Cervantes, J., Oak, E., Garcia, J., Liu, H., Lorenzini, P. A., Batra, D., Chhabra, A., Salazar, J. C., & Roca, X. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.04.021 · Cited by 22
Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications
Fonseca, K. L., Lozano, J. J., Despuig, A., Habgood-Coote, D., Sidorova, J., Aznar, D., Arias, L., Río-Álvarez, Á. D., Carrillo-Reixach, J., Goff, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60255-w · Cited by 21
Self-citationLefrançais, E., Hudrisier, D., Neyrolles, O., Behar, S. M., & Ernst, J. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01192-z · Cited by 23
Inhibition of type I interferon signaling abrogates early Mycobacterium bovis infection
Wang, J., Hussain, T. A., Zhang, K., Liao, Y., Yao, J., Song, Y., Sabir, N., Cheng, G., Dong, H., Li, M., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4654-3 · Cited by 21
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future
Günther, G., Heyckendorf, J., Zellweger, J. P., Reimann, M., Claassens, M. M., Chesov, D., & van Leth, F. (2021) · Respiration · doi:10.1159/000516392 · Cited by 22
Rémot, A., Carreras, F., Coupé, A., Doz, E., Boschiroli, M. L., Browne, J. A., Marquant, Q., Descamps, D., Archer, F., Aseffa, A., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.696525 · Cited by 21
Host lipidome and tuberculosis treatment failure
Shivakoti, R., Newman, J. W. I., Hanna, L. E., Queiroz, A. T. L., Borkowski, K., Gupte, A., Paradkar, M., Satyamurthi, P., Kulkarni, V., Selva, M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04532-2020 · Cited by 21
Advancing personalized medicine for tuberculosis through the application of immune profiling
Thu, V. T. A., Ly, D. D., Jayanti, R. P., Trinh, H. K. T., Hung, T. M., Cho, Y., Long, N. P., & Shin, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1108155 · Cited by 24
Bettering BCG: a tough task for a TB vaccine?
Bishai, W. R., Sullivan, Z. A., Bloom, B. R., & Andersen, P. L. (2013) · Nature Medicine · doi:10.1038/nm.3153 · Cited by 21
Li, Y., Tsun, A., Gao, Z., Han, Z., Gao, Y., Li, Z., Lin, F., Wang, Y., Wei, G., Yao, Z., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430207 · Cited by 21
High throughput cellular screens to interrogate the human T and B cell repertoires
Corti, D., Sallusto, F., & Lanzavecchia, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.04.006 · Cited by 21
Peripheral T Cell Cytokine Responses for Diagnosis of Active Tuberculosis
Nemeth, J., Winkler, H., Zwick, R. H., Müller, C., Rumetshofer, R., Boeck, L., Burghuber, O. C., & Winkler, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035290 · Cited by 21
Microbial pathogenesis and type III interferons
Cohen, T. S., & Parker, D. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.005 · Cited by 21
Doedens, J. R., Jones, W. D., Hill, K., Mason, M. J., Gersuk, V. H., Mease, P. J., Dall’Era, M., Aranow, C. B., Martin, R. W., Cohen, S. B., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601142 · Cited by 21
Self-citationWang, S., Zhang, J., Sui, L., Xu, H. Y., Piao, Q., Liu, Y., Qu, X., Sun, Y., Song, L., Li, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14808-9 · Cited by 21
Guan, W., Yang, Z., Wu, N. C., Lee, H. H. Y., Li, Y., Jiang, W., Shen, L., Wu, D. C., Chen, R., Zhong, N., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy317 · Cited by 21
Mahomed, S., Padayatchi, N., Singh, J. A., & Naidoo, K. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.03.006 · Cited by 21
Metformin in tuberculosis: beyond control of hyperglycemia
Oglesby, W., Kara, A. M., Granados, H., & Cervantes, J. (2019) · Infection · doi:10.1007/s15010-019-01322-5 · Cited by 21
New Concepts in Tuberculosis Host Defense
Lewinsohn, D. M., & Lewinsohn, D. A. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.07.002 · Cited by 22
Choudhary, E., Bullen, C. K., Goel, R., Singh, A. K., Praharaj, M., Thakur, P., Dhiman, R., Bishai, W. R., & Agarwal, N. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00895 · Cited by 21
Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malaria
Dieng, M. M., Diawara, A., Vinu, M., Jarkass, H. T. E., Sermé, S. S., Sombié, S., Barry, A., Coulibaly, S. A., Diarra, A., Drou, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18915-6 · Cited by 21
Immunology ofMycobacterium tuberculosisInfections
Sia, J. K., & Rengarajan, J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch64 · Cited by 22
A blood RNA transcriptome signature for COVID-19
Kwan, P. K. W., Cross, G. B., Naftalin, C. M., Ahidjo, B. A., Mok, C. K., Fanusi, F., Sari, I. P., Chia, S. C., Kumar, S. K., Alagha, R., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01006-w · Cited by 21
Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
Pennings, J. L. A., Schuurhof, A., Hodemaekers, H. M., Buisman, A., de Rond, L., Widjojoatmodjo, M. N., Luytjes, W., Kimpen, J. L. L., Bont, L., & Janssen, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021461 · Cited by 21
Zárate-Bladés, C. R., Silva, C. L., & Passos, G. A. S. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/192630 · Cited by 22
Betsou, F., Parida, S. K., & Guillerm, M. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.07.006 · Cited by 21
Mitraphylline inhibits lipopolysaccharide-mediated activation of primary human neutrophils
la Paz, S. M., Fernández, Á., la Puerta, R. D., Quilez, A. M., Muriana, F. J. G., García, M. D., & Bermúdez, B. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.12.015 · Cited by 21
Pre-symptomatic diagnosis and treatment of filovirus diseases
Shurtleff, A. C., Whitehouse, C. A., Ward, M. D., Cazares, L. H., & Bavari, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00108 · Cited by 22
The Changing Burden of Infectious Disease in Europe
Fears, R., van der Meer, J. W. M., & ter Meulen, V. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002556 · Cited by 21
Vail, K. J., da Silveira, B. P., Bell, S. L., Bordin, A. I., Cohen, N. D., Patrick, K. L., & Watson, R. O. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009888 · Cited by 20
Mir, M. A., Mir, B., Kumawat, M., Alkhanani, M., & Jan, U. (2022) · Future Microbiology · doi:10.2217/fmb-2022-0026 · Cited by 20
Baker, P. J., Amaral, E. P., Castro, E., Bohrer, A. C., Torres-Juárez, F., Jordan, C. M., Nelson, C. E., Barber, D. L., Johnson, R. F., Hilligan, K. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1240419 · Cited by 20
Conejero, L., Potempa, K., Graham, C. M., Spink, N., Blankley, S., Salguero, F. J., Sranujit, R. P., Khaenam, P., Banchereau, J., Pascual, V., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500641 · Cited by 20
Self-citationImmune protection against tuberculosis – When is immunotherapy preferable to vaccination?
Grange, J. M., Brunet, L. R., & Rieder, H. L. (2011) · Tuberculosis · doi:10.1016/j.tube.2010.12.004 · Cited by 20
GuhaThakurta, D., Sheikh, N. A., Meagher, T. C., Letarte, S., & Trager, J. B. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.811814 · Cited by 20
Booty, M. G., Nunes-Alves, C., Carpenter, S. M., Jayaraman, P., & Behar, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502206 · Cited by 20
Treatment associated inflammatory deterioration in tuberculous meningitis: unpicking the paradox
Thương, N. T. T., & Thwaites, G. E. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw565 · Cited by 20
The role of human host genetics in tuberculosis resistance
Kinnear, C. J., Hoal, E. G., Schurz, H., van Helden, P. D., & Möller, M. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1354700 · Cited by 20
Human Genomics of Mycobacterium tuberculosis Infection and Disease
Orlova, M., & Schurr, E. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0124-7 · Cited by 20
Hemingway, C. A., Berk, M., Anderson, S. T. B., Wright, V., Hamilton, S., Eleftherohorinou, H., Kaforou, M., Goldgof, G. M., Hickman, K., Kampmann, B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185973 · Cited by 21
An Accord of Nuclear Receptor Expression in M. tuberculosis Infected Macrophages and Dendritic Cells
Saini, A., Mahajan, S., Ahuja, N., Bhagyaraj, E., Kalra, R., Janmeja, A. K., & Gupta, P. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20769-4 · Cited by 20
Metadata
- Authors
- Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., Chaussabel, D., & O’Garra, A.
- Affiliations
- National Institute for Medical Research (GB)
- Inserm (FR)
- Imperial College Healthcare NHS Trust (GB)
- University of Cape Town (ZA)
- The University of Texas Southwestern Medical Center (US)
- Baylor Scott & White Health (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- O’Garra, Anne
- ORCID
- Venue
- Nature
- Published
- 2010-08
- Volume
- 466
- Issue
- 7309
- Pages
- 973-977
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3492754
- OpenAlex
- W2109543073
- Cited by
- 1,898
- References
- 29
- Citations by year
- 2026: 104 · 2025: 105 · 2024: 112 · 2023: 108 · 2022: 99 · 2021: 121 · 2020: 113 · 2019: 127 · 2018: 137 · 2017: 134 · 2016: 149 · 2015: 126 · 2014: 119 · 2013: 127 · 2012: 114
- FWCI
- 70.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (088316, 84323)
- Imperial College Healthcare NHS Trust
- U.S. Public Health Service (U19 AIO57234-02, P50 ARO54083)
- Medical Research Council
- National Cancer Institute (P01CA084512)
- National Institute of Allergy and Infectious Diseases (U19AI057234, U01AI082110, U19AI082715)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR050770, P50AR054083)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- tuberculosis, Mycobacterium tuberculosis, latent tuberculosis infection, active tuberculosis, whole blood transcriptome, interferon-stimulated genes, neutrophils, interferon-gamma signaling, type I interferon, transcriptomic biomarkers, diagnostic biomarkers, prognostic factors, systemic lupus erythematosus, cell composition, treatment response monitoring
- MeSH terms
- Blood, Gene Expression Regulation, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Mycobacterium tuberculosis, Neutrophils, Transcription, Genetic, Tuberculosis, Tuberculosis, Pulmonary, Signal Transduction, Case-Control Studies, Gene Expression Profiling, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review